Ongoing preclinical trials and translational research into the PD-1/PD-L1 axis in lymphoma will assess the effectiveness of PD-1/PD-L1 inhibitors in PD-1/PD-L1-positive r/r B cell and T cell lymphoma. The gene discussed is CD274; the disease is lymphoma.